Skip to main content

Table 1 Main characteristics of all 42 patients with advanced biliary tract cancer

From: A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

Characteristics

Number of pts (N = 42)

Sex

 Male

17 (40.5%)

 Female

25 (59.5%)

Age (years)

 Median (range)

67 (36–84)

  ≤ 65

18 (42.9%)

  > 65

24 (57.1%)

WHO PS

 0

23 (54.8%)

 1

19 (45.2%)

Primary tumor location

 Intrahepatic CCA

21 (50.0%)

 Other locations:

21 (50.0%)

  Gallbladder

8 (19.0%)

  Perihilar CCA

7 (16.7%)

  Distal CCA

4 (9.5%)

  Ampulloma

2 (4.8%)

Disease extension

 Locally advanced (LA)

10 (23.8%)

 Metastatic (M)

32 (76.2%)

Site of metastases

 None (LA)

10 (23.8%)

 M in liver only

11 (26.2%)

 M in liver + other sites

15 (35.7%)

 M in other sites only

6 (14.3%)

Biliary stent placed

14 (33.3%)